Astal Laboratories' Stock Upgraded to 'Buy' by MarketsMOJO, Reports 24000% Growth in Operating Profit
Astal Laboratories, a microcap trading company, has been upgraded to a 'Buy' by MarketsMojo after reporting a staggering 24000% growth in operating profit for the quarter ending June 2024. Its net sales and PBDIT have also shown significant improvement. The stock is in a bullish trend and has outperformed the BSE 500 in the last three years. However, investors should be aware of the company's weak long-term fundamentals and expensive valuation.
Astal Laboratories, a microcap trading company, has recently caught the attention of investors as its stock has been upgraded to a 'Buy' by MarketsMOJO on August 29, 2024. This upgrade comes after the company declared very positive results for the quarter ending June 2024, with a growth in operating profit of a staggering 24000%. This is the second consecutive quarter where the company has reported positive results.In addition, the company's net sales for the half year were higher at Rs 25.40 crore and its PBDIT for the quarter was the highest at Rs 2.38 crore. The stock is also technically in a bullish range, with multiple factors such as MACD, Bollinger Band, KST, DOW, and OBV all indicating a positive trend. This has resulted in a 95.98% return since July 2, 2024.
One of the major factors contributing to the stock's bullish trend is its consistent returns over the last three years. Not only has it generated a remarkable 268.98% return in the last year, but it has also outperformed the BSE 500 in each of the last three annual periods. This is a testament to the company's strong performance and growth potential.
However, there are some risks to consider when investing in Astal Laboratories. The company has a weak long-term fundamental strength, with an average return on equity (ROE) of only 0.19%. Its long-term growth has also been poor, with an annual growth rate of only 2.83% over the last five years. Additionally, the company's ability to service its debt is weak, with a poor EBIT to interest ratio of -0.21.
Furthermore, the stock is currently trading at an expensive valuation with a price to book value of 4.7. However, it is still trading at a discount compared to its average historical valuations. Despite this, the stock has generated a remarkable return of 268.98% in the past year, with profits rising by 273%. This shows the company's potential for growth and profitability.
In conclusion, Astal Laboratories is a microcap trading company that has shown strong performance and growth potential. With its recent upgrade to a 'Buy' by MarketsMOJO and consistent returns over the last three years, it is definitely a stock to keep an eye on. However, investors should also consider the risks involved, such as weak long-term fundamentals and an expensive valuation.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
